FOXO4-DRI 10 mg is a D-Retro-Inverso peptide analogue under investigation in cellular-senescence and aging research. Studied in senolytic and longevity research models.
Research Profile
- D-Retro-Inverso FOXO4 peptide
- Studied in cellular-senescence, senolytic, and aging research
- Active area of longevity research
- QC verified by HPLC and mass spectrometry
Specifications
- Compound: FOXO4-DRI
- Dosage: 10 mg per vial
- Purity: ≥ 98% (HPLC)
- Form: Lyophilized powder
- Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
